Le Lézard
Classified in: Health, Science and technology
Subject: PER

Dan Cebula, Vice President for Connected Health at KORE, Appointed to Board of Directors for The Medical Alert Monitoring Association


ATLANTA , April 25, 2024 /PRNewswire/ -- KORE, a global leader in Internet of Things ("IoT") Solutions and pioneering IoT hyperscaler, and provider of IoT Connectivity, Solutions and Analytics, announced today the appointment of Dan Cebula, Vice President for Connected Health of KORE, to the Board of Directors of the Medical Alert Monitoring Association (MAMA). Cebula, along with five other new additions to the board, will help represent the needs of the medical alert monitoring and personal emergency response services industry.

MAMA Board of Directors President, Geoff Gross, welcomed Cebula saying, "I'm very pleased to welcome Dan to the board and have him represent KORE in our association's efforts to drive awareness, advocacy, and growth for the personal emergency response system (PERS) category.  Dan has been a leader in the industry for almost a decade, helping establish KORE as a leading IoT connectivity platform for large service providers. He will most certainly bring a new perspective and expertise to our ambitious initiatives that are underway."

Cebula, who has spent over a decade with KORE, said he is looking forward to continuing the company's enduring partnership with MAMA.

"MAMA is the only professional trade association representing the needs of the industry as a whole, and KORE is the only connectivity enabler helping them achieve that," said Cebula. "The relationship between our organizations makes sense on every level, and we cannot wait to see what innovations continue to grow from it."

Romil Bahl, KORE President and CEO, said KORE is honored to have Cebula recognized as a trusted advisor to the industry, MAMA and its members.

"IoT and the medical alert monitoring industry are deeply intertwined, but what bonds KORE and MAMA the most is our shared commitment to creating better health outcomes for patients and their families," said Bahl. "We are thrilled to help MAMA in their mission to make the industry a better place by advocating on behalf of legislation and regulations that enhance end-user safety."

For more information, visit korewireless.com and mama.org.

About KORE
KORE is a pioneer, leader, and trusted advisor delivering mission critical IoT solutions and services. We empower organizations of all sizes to improve operational and business results by simplifying the complexity of IoT. Our deep IoT knowledge and experience, global reach, purpose-built solutions, and deployment agility accelerate and materially impact our customers' business outcomes. For more information, visit korewireless.com.

KORE Media Contact
Stephen Bell
Senior Content Marketing Manager
Email: [email protected]
+1-440-622-9352

SOURCE KORE Wireless


These press releases may also interest you

at 00:01
America's child care supply remains flat, while child care prices continue to increase, according to a new report released today by Child Care Aware® of America (CCAoA) that highlights the burden families face accessing quality and affordable child...

at 00:01
The cost of living is Gen Zs' and millennials' top societal concern, but green shoots of optimism for the economy and their personal finances are emergingNearly nine in 10 Gen Zs and millennials say purpose is important to their job satisfaction and...

at 00:00
AmacaThera Inc, a clinical stage biotechnology company specializing in the development of advanced sustained release hydrogel formulations, has dosed its first human subject with AMT-143, the company's lead asset in non-opioid acute pain management. ...

14 mai 2024
BioArctic AB's (publ) partner Eisai today said that they expect Leqembi sales to total JPY 56.5 billion (approximately SEK 4 billion) for their fiscal year (FY) 2024 (April 2024 through March 2025). This would generate approximately SEK 360 M in net...

14 mai 2024
The global flow cytometry market  size is estimated to grow by USD 6038.44 million from 2023-2027, according to Technavio. The market is estimated to grow at a CAGR of about 13.12%  during the forecast period....

14 mai 2024
BioArctic AB's (publ) partner Eisai announced today that they have initiated the rolling submission of a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for lecanemab-irmb (U.S. brand name: Leqembi) subcutaneous...



News published on and distributed by: